Screening of Predictive Biomarkers for Cardiorenal Syndrome — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Screening of Predictive Biomarkers for Cardiorenal Syndrome — Stella

Home/Cardiorenal Syndrome (CRS)/

View on ClinicalTrials.gov

Recruiting

Back to Cardiorenal Syndrome (CRS) trials

Trial locations(1 site)

China

The Affiliated Hospital of Nantong University, Nantong, Jiangsu

Key details

Sponsor

Haiyan Pan

Enrollment target

~150 participants

Started

September 2025

Primary completion

October 2026

Age range

18 Years – 75 Years

Last updated February 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.